Related Experiment Video
Updated: Oct 20, 2025

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.5K
Bilateral occlusive retinal vasculitis associated with primary sclerosing cholangitis
Abdus S Ansari1, Catrin Bertalot1, Divya Mathews1
1Department of Ophthalmology, Stanley Eye Unit, Betsi Cadwaladr University Health Board United Kingdom, Abergele, Wales, UK.
Summary
This case study explores a potential link between primary sclerosing cholangitis (PSC) and vision loss. Androgenic-anabolic steroid use may suppress ocular autoimmune disease in PSC patients.
Area of Science:
- Ophthalmology
- Gastroenterology
- Endocrinology
Background:
- Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease with poorly understood etiology.
- Ocular manifestations in PSC patients are uncommon, with limited literature on their association.
- Autoimmune phenomena are implicated in PSC, but direct links to specific ocular conditions remain unclear.
Observation:
- A 46-year-old male diagnosed with PSC presented with bilateral panuveitis and occlusive retinal vasculitis.
- The patient was a lifelong bodybuilder with a history of prolonged androgenic-anabolic steroid (AAS) use.
- Ocular symptoms emerged after cessation of AAS, despite normal autoimmune markers.
Findings:
- The clinical presentation suggests a potential link between PSC and AAS-induced immunosuppression leading to ocular autoimmune disease.
- Androgenic-anabolic steroids may have suppressed latent ocular autoimmune activity, with symptoms manifesting upon withdrawal.
- This case highlights the complex interplay between liver disease, steroid use, and autoimmune responses in the eye.
Implications:
- Further research is needed to elucidate the relationship between PSC, AAS use, and the development of occlusive panuveitis.
- Ophthalmologists and gastroenterologists should consider AAS history in PSC patients presenting with unexplained uveitis or retinal vasculitis.
- This case underscores the importance of a comprehensive patient history, including substance use, in diagnosing complex conditions.
Related Concept Videos
Chronic Bowel Disorders: Introduction
569
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
569
Chronic Pancreatitis II: Collaborative Care
143
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
143
Diseases of the Liver and Gallbladder
1.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K

